nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Abdominal pain—Sorafenib—kidney cancer	0.00101	0.00101	CcSEcCtD
Gadodiamide—Diarrhoea—Everolimus—kidney cancer	0.001	0.001	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Sunitinib—kidney cancer	0.001	0.001	CcSEcCtD
Gadodiamide—Hyperhidrosis—Vincristine—kidney cancer	0.001	0.001	CcSEcCtD
Gadodiamide—Pruritus—Erlotinib—kidney cancer	0.001	0.001	CcSEcCtD
Gadodiamide—Fatigue—Dactinomycin—kidney cancer	0.001	0.001	CcSEcCtD
Gadodiamide—Pain—Dactinomycin—kidney cancer	0.000992	0.000992	CcSEcCtD
Gadodiamide—Dysgeusia—Paclitaxel—kidney cancer	0.000988	0.000988	CcSEcCtD
Gadodiamide—Anaphylactic shock—Gemcitabine—kidney cancer	0.000983	0.000983	CcSEcCtD
Gadodiamide—Oedema—Gemcitabine—kidney cancer	0.000983	0.000983	CcSEcCtD
Gadodiamide—Infection—Gemcitabine—kidney cancer	0.000977	0.000977	CcSEcCtD
Gadodiamide—Dizziness—Vinblastine—kidney cancer	0.000974	0.000974	CcSEcCtD
Gadodiamide—Dizziness—Everolimus—kidney cancer	0.00097	0.00097	CcSEcCtD
Gadodiamide—Abdominal pain—Sunitinib—kidney cancer	0.000969	0.000969	CcSEcCtD
Gadodiamide—Body temperature increased—Sunitinib—kidney cancer	0.000969	0.000969	CcSEcCtD
Gadodiamide—Diarrhoea—Erlotinib—kidney cancer	0.000968	0.000968	CcSEcCtD
Gadodiamide—Hypotension—Vincristine—kidney cancer	0.000968	0.000968	CcSEcCtD
Gadodiamide—Nervous system disorder—Gemcitabine—kidney cancer	0.000964	0.000964	CcSEcCtD
Gadodiamide—Renal failure acute—Doxorubicin—kidney cancer	0.00096	0.00096	CcSEcCtD
Gadodiamide—Feeling abnormal—Dactinomycin—kidney cancer	0.000956	0.000956	CcSEcCtD
Gadodiamide—Rhinitis—Capecitabine—kidney cancer	0.000953	0.000953	CcSEcCtD
Gadodiamide—Hyperhidrosis—Gemcitabine—kidney cancer	0.00095	0.00095	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000949	0.000949	CcSEcCtD
Gadodiamide—Hot flush—Doxorubicin—kidney cancer	0.000947	0.000947	CcSEcCtD
Gadodiamide—Tremor—Paclitaxel—kidney cancer	0.000945	0.000945	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000944	0.000944	CcSEcCtD
Gadodiamide—Pharyngitis—Capecitabine—kidney cancer	0.000944	0.000944	CcSEcCtD
Gadodiamide—Urinary tract disorder—Capecitabine—kidney cancer	0.000939	0.000939	CcSEcCtD
Gadodiamide—Menopausal symptoms—Doxorubicin—kidney cancer	0.000939	0.000939	CcSEcCtD
Gadodiamide—Hypersensitivity—Sorafenib—kidney cancer	0.000938	0.000938	CcSEcCtD
Gadodiamide—Vomiting—Vinblastine—kidney cancer	0.000936	0.000936	CcSEcCtD
Gadodiamide—Dizziness—Erlotinib—kidney cancer	0.000936	0.000936	CcSEcCtD
Gadodiamide—Ill-defined disorder—Paclitaxel—kidney cancer	0.000936	0.000936	CcSEcCtD
Gadodiamide—Vomiting—Everolimus—kidney cancer	0.000933	0.000933	CcSEcCtD
Gadodiamide—Urethral disorder—Capecitabine—kidney cancer	0.000932	0.000932	CcSEcCtD
Gadodiamide—Renal impairment—Doxorubicin—kidney cancer	0.000931	0.000931	CcSEcCtD
Gadodiamide—Paraesthesia—Vincristine—kidney cancer	0.000931	0.000931	CcSEcCtD
Gadodiamide—Rash—Everolimus—kidney cancer	0.000925	0.000925	CcSEcCtD
Gadodiamide—Dermatitis—Everolimus—kidney cancer	0.000924	0.000924	CcSEcCtD
Gadodiamide—Headache—Vinblastine—kidney cancer	0.000923	0.000923	CcSEcCtD
Gadodiamide—Headache—Everolimus—kidney cancer	0.000919	0.000919	CcSEcCtD
Gadodiamide—Hypotension—Gemcitabine—kidney cancer	0.000919	0.000919	CcSEcCtD
Gadodiamide—Body temperature increased—Dactinomycin—kidney cancer	0.000917	0.000917	CcSEcCtD
Gadodiamide—Abdominal pain—Dactinomycin—kidney cancer	0.000917	0.000917	CcSEcCtD
Gadodiamide—Visual impairment—Capecitabine—kidney cancer	0.000916	0.000916	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000915	0.000915	CcSEcCtD
Gadodiamide—Asthenia—Sorafenib—kidney cancer	0.000914	0.000914	CcSEcCtD
Gadodiamide—Malaise—Paclitaxel—kidney cancer	0.00091	0.00091	CcSEcCtD
Gadodiamide—Cardiac failure—Doxorubicin—kidney cancer	0.000908	0.000908	CcSEcCtD
Gadodiamide—Syncope—Paclitaxel—kidney cancer	0.000904	0.000904	CcSEcCtD
Gadodiamide—Hypersensitivity—Sunitinib—kidney cancer	0.000903	0.000903	CcSEcCtD
Gadodiamide—Pruritus—Sorafenib—kidney cancer	0.000901	0.000901	CcSEcCtD
Gadodiamide—Vomiting—Erlotinib—kidney cancer	0.0009	0.0009	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000896	0.000896	CcSEcCtD
Gadodiamide—Fatigue—Vincristine—kidney cancer	0.000894	0.000894	CcSEcCtD
Gadodiamide—Rash—Erlotinib—kidney cancer	0.000892	0.000892	CcSEcCtD
Gadodiamide—Dermatitis—Erlotinib—kidney cancer	0.000892	0.000892	CcSEcCtD
Gadodiamide—Hyponatraemia—Doxorubicin—kidney cancer	0.00089	0.00089	CcSEcCtD
Gadodiamide—Headache—Erlotinib—kidney cancer	0.000887	0.000887	CcSEcCtD
Gadodiamide—Tinnitus—Capecitabine—kidney cancer	0.000887	0.000887	CcSEcCtD
Gadodiamide—Loss of consciousness—Paclitaxel—kidney cancer	0.000886	0.000886	CcSEcCtD
Gadodiamide—Pain—Vincristine—kidney cancer	0.000886	0.000886	CcSEcCtD
Gadodiamide—Paraesthesia—Gemcitabine—kidney cancer	0.000883	0.000883	CcSEcCtD
Gadodiamide—Flushing—Capecitabine—kidney cancer	0.000882	0.000882	CcSEcCtD
Gadodiamide—Asthenia—Sunitinib—kidney cancer	0.000879	0.000879	CcSEcCtD
Gadodiamide—Dyspnoea—Gemcitabine—kidney cancer	0.000877	0.000877	CcSEcCtD
Gadodiamide—Nausea—Vinblastine—kidney cancer	0.000875	0.000875	CcSEcCtD
Gadodiamide—Somnolence—Gemcitabine—kidney cancer	0.000874	0.000874	CcSEcCtD
Gadodiamide—Convulsion—Paclitaxel—kidney cancer	0.000874	0.000874	CcSEcCtD
Gadodiamide—Migraine—Doxorubicin—kidney cancer	0.000872	0.000872	CcSEcCtD
Gadodiamide—Nausea—Everolimus—kidney cancer	0.000871	0.000871	CcSEcCtD
Gadodiamide—Diarrhoea—Sorafenib—kidney cancer	0.000871	0.000871	CcSEcCtD
Gadodiamide—Pruritus—Sunitinib—kidney cancer	0.000867	0.000867	CcSEcCtD
Gadodiamide—Arthralgia—Paclitaxel—kidney cancer	0.000859	0.000859	CcSEcCtD
Gadodiamide—Chest pain—Paclitaxel—kidney cancer	0.000859	0.000859	CcSEcCtD
Gadodiamide—Myalgia—Paclitaxel—kidney cancer	0.000859	0.000859	CcSEcCtD
Gadodiamide—Anxiety—Paclitaxel—kidney cancer	0.000856	0.000856	CcSEcCtD
Gadodiamide—Hypersensitivity—Dactinomycin—kidney cancer	0.000855	0.000855	CcSEcCtD
Gadodiamide—Chills—Capecitabine—kidney cancer	0.000853	0.000853	CcSEcCtD
Gadodiamide—Arrhythmia—Capecitabine—kidney cancer	0.000849	0.000849	CcSEcCtD
Gadodiamide—Discomfort—Paclitaxel—kidney cancer	0.000848	0.000848	CcSEcCtD
Gadodiamide—Fatigue—Gemcitabine—kidney cancer	0.000848	0.000848	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Vincristine—kidney cancer	0.000847	0.000847	CcSEcCtD
Gadodiamide—Dizziness—Sorafenib—kidney cancer	0.000842	0.000842	CcSEcCtD
Gadodiamide—Pain—Gemcitabine—kidney cancer	0.000841	0.000841	CcSEcCtD
Gadodiamide—Nausea—Erlotinib—kidney cancer	0.000841	0.000841	CcSEcCtD
Gadodiamide—Dry mouth—Paclitaxel—kidney cancer	0.00084	0.00084	CcSEcCtD
Gadodiamide—Diarrhoea—Sunitinib—kidney cancer	0.000838	0.000838	CcSEcCtD
Gadodiamide—Ataxia—Doxorubicin—kidney cancer	0.000833	0.000833	CcSEcCtD
Gadodiamide—Asthenia—Dactinomycin—kidney cancer	0.000832	0.000832	CcSEcCtD
Gadodiamide—Blood creatinine increased—Doxorubicin—kidney cancer	0.00083	0.00083	CcSEcCtD
Gadodiamide—Oedema—Paclitaxel—kidney cancer	0.000823	0.000823	CcSEcCtD
Gadodiamide—Anaphylactic shock—Paclitaxel—kidney cancer	0.000823	0.000823	CcSEcCtD
Gadodiamide—Abdominal pain—Vincristine—kidney cancer	0.000819	0.000819	CcSEcCtD
Gadodiamide—Body temperature increased—Vincristine—kidney cancer	0.000819	0.000819	CcSEcCtD
Gadodiamide—Infection—Paclitaxel—kidney cancer	0.000818	0.000818	CcSEcCtD
Gadodiamide—Dysgeusia—Capecitabine—kidney cancer	0.000811	0.000811	CcSEcCtD
Gadodiamide—Dizziness—Sunitinib—kidney cancer	0.00081	0.00081	CcSEcCtD
Gadodiamide—Feeling abnormal—Gemcitabine—kidney cancer	0.00081	0.00081	CcSEcCtD
Gadodiamide—Shock—Paclitaxel—kidney cancer	0.00081	0.00081	CcSEcCtD
Gadodiamide—Vomiting—Sorafenib—kidney cancer	0.00081	0.00081	CcSEcCtD
Gadodiamide—Nervous system disorder—Paclitaxel—kidney cancer	0.000807	0.000807	CcSEcCtD
Gadodiamide—Tachycardia—Paclitaxel—kidney cancer	0.000803	0.000803	CcSEcCtD
Gadodiamide—Rash—Sorafenib—kidney cancer	0.000803	0.000803	CcSEcCtD
Gadodiamide—Dermatitis—Sorafenib—kidney cancer	0.000802	0.000802	CcSEcCtD
Gadodiamide—Headache—Sorafenib—kidney cancer	0.000798	0.000798	CcSEcCtD
Gadodiamide—Hyperhidrosis—Paclitaxel—kidney cancer	0.000796	0.000796	CcSEcCtD
Gadodiamide—Diarrhoea—Dactinomycin—kidney cancer	0.000794	0.000794	CcSEcCtD
Gadodiamide—Vomiting—Sunitinib—kidney cancer	0.000779	0.000779	CcSEcCtD
Gadodiamide—Body temperature increased—Gemcitabine—kidney cancer	0.000777	0.000777	CcSEcCtD
Gadodiamide—Tremor—Capecitabine—kidney cancer	0.000775	0.000775	CcSEcCtD
Gadodiamide—Rash—Sunitinib—kidney cancer	0.000773	0.000773	CcSEcCtD
Gadodiamide—Dermatitis—Sunitinib—kidney cancer	0.000772	0.000772	CcSEcCtD
Gadodiamide—Hypotension—Paclitaxel—kidney cancer	0.000769	0.000769	CcSEcCtD
Gadodiamide—Ill-defined disorder—Capecitabine—kidney cancer	0.000768	0.000768	CcSEcCtD
Gadodiamide—Headache—Sunitinib—kidney cancer	0.000768	0.000768	CcSEcCtD
Gadodiamide—Hypersensitivity—Vincristine—kidney cancer	0.000764	0.000764	CcSEcCtD
Gadodiamide—Nausea—Sorafenib—kidney cancer	0.000756	0.000756	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00075	0.00075	CcSEcCtD
Gadodiamide—Malaise—Capecitabine—kidney cancer	0.000746	0.000746	CcSEcCtD
Gadodiamide—Asthenia—Vincristine—kidney cancer	0.000744	0.000744	CcSEcCtD
Gadodiamide—Syncope—Capecitabine—kidney cancer	0.000742	0.000742	CcSEcCtD
Gadodiamide—Paraesthesia—Paclitaxel—kidney cancer	0.000739	0.000739	CcSEcCtD
Gadodiamide—Vomiting—Dactinomycin—kidney cancer	0.000738	0.000738	CcSEcCtD
Gadodiamide—Dyspnoea—Paclitaxel—kidney cancer	0.000734	0.000734	CcSEcCtD
Gadodiamide—Somnolence—Paclitaxel—kidney cancer	0.000732	0.000732	CcSEcCtD
Gadodiamide—Rash—Dactinomycin—kidney cancer	0.000731	0.000731	CcSEcCtD
Gadodiamide—Nausea—Sunitinib—kidney cancer	0.000728	0.000728	CcSEcCtD
Gadodiamide—Loss of consciousness—Capecitabine—kidney cancer	0.000727	0.000727	CcSEcCtD
Gadodiamide—Dyspepsia—Paclitaxel—kidney cancer	0.000725	0.000725	CcSEcCtD
Gadodiamide—Fatigue—Paclitaxel—kidney cancer	0.00071	0.00071	CcSEcCtD
Gadodiamide—Diarrhoea—Vincristine—kidney cancer	0.000709	0.000709	CcSEcCtD
Gadodiamide—Asthenia—Gemcitabine—kidney cancer	0.000705	0.000705	CcSEcCtD
Gadodiamide—Chest pain—Capecitabine—kidney cancer	0.000705	0.000705	CcSEcCtD
Gadodiamide—Arthralgia—Capecitabine—kidney cancer	0.000705	0.000705	CcSEcCtD
Gadodiamide—Myalgia—Capecitabine—kidney cancer	0.000705	0.000705	CcSEcCtD
Gadodiamide—Pain—Paclitaxel—kidney cancer	0.000704	0.000704	CcSEcCtD
Gadodiamide—Anxiety—Capecitabine—kidney cancer	0.000702	0.000702	CcSEcCtD
Gadodiamide—Discomfort—Capecitabine—kidney cancer	0.000696	0.000696	CcSEcCtD
Gadodiamide—Pruritus—Gemcitabine—kidney cancer	0.000696	0.000696	CcSEcCtD
Gadodiamide—Dry mouth—Capecitabine—kidney cancer	0.000689	0.000689	CcSEcCtD
Gadodiamide—Nausea—Dactinomycin—kidney cancer	0.000689	0.000689	CcSEcCtD
Gadodiamide—Dizziness—Vincristine—kidney cancer	0.000685	0.000685	CcSEcCtD
Gadodiamide—Feeling abnormal—Paclitaxel—kidney cancer	0.000678	0.000678	CcSEcCtD
Gadodiamide—Oedema—Capecitabine—kidney cancer	0.000676	0.000676	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000673	0.000673	CcSEcCtD
Gadodiamide—Diarrhoea—Gemcitabine—kidney cancer	0.000673	0.000673	CcSEcCtD
Gadodiamide—Renal failure—Doxorubicin—kidney cancer	0.000671	0.000671	CcSEcCtD
Gadodiamide—Infection—Capecitabine—kidney cancer	0.000671	0.000671	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000669	0.000669	CcSEcCtD
Gadodiamide—Shock—Capecitabine—kidney cancer	0.000665	0.000665	CcSEcCtD
Gadodiamide—Nervous system disorder—Capecitabine—kidney cancer	0.000662	0.000662	CcSEcCtD
Gadodiamide—Tachycardia—Capecitabine—kidney cancer	0.000659	0.000659	CcSEcCtD
Gadodiamide—Vomiting—Vincristine—kidney cancer	0.000659	0.000659	CcSEcCtD
Gadodiamide—Urticaria—Paclitaxel—kidney cancer	0.000654	0.000654	CcSEcCtD
Gadodiamide—Rash—Vincristine—kidney cancer	0.000653	0.000653	CcSEcCtD
Gadodiamide—Hyperhidrosis—Capecitabine—kidney cancer	0.000653	0.000653	CcSEcCtD
Gadodiamide—Dermatitis—Vincristine—kidney cancer	0.000653	0.000653	CcSEcCtD
Gadodiamide—Abdominal pain—Paclitaxel—kidney cancer	0.000651	0.000651	CcSEcCtD
Gadodiamide—Body temperature increased—Paclitaxel—kidney cancer	0.000651	0.000651	CcSEcCtD
Gadodiamide—Headache—Vincristine—kidney cancer	0.000649	0.000649	CcSEcCtD
Gadodiamide—Hypotension—Capecitabine—kidney cancer	0.000631	0.000631	CcSEcCtD
Gadodiamide—Vomiting—Gemcitabine—kidney cancer	0.000625	0.000625	CcSEcCtD
Gadodiamide—Rash—Gemcitabine—kidney cancer	0.00062	0.00062	CcSEcCtD
Gadodiamide—Dermatitis—Gemcitabine—kidney cancer	0.000619	0.000619	CcSEcCtD
Gadodiamide—Headache—Gemcitabine—kidney cancer	0.000616	0.000616	CcSEcCtD
Gadodiamide—Nausea—Vincristine—kidney cancer	0.000616	0.000616	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000615	0.000615	CcSEcCtD
Gadodiamide—Rhinitis—Doxorubicin—kidney cancer	0.000614	0.000614	CcSEcCtD
Gadodiamide—Pharyngitis—Doxorubicin—kidney cancer	0.000608	0.000608	CcSEcCtD
Gadodiamide—Paraesthesia—Capecitabine—kidney cancer	0.000607	0.000607	CcSEcCtD
Gadodiamide—Hypersensitivity—Paclitaxel—kidney cancer	0.000606	0.000606	CcSEcCtD
Gadodiamide—Urinary tract disorder—Doxorubicin—kidney cancer	0.000605	0.000605	CcSEcCtD
Gadodiamide—Dyspnoea—Capecitabine—kidney cancer	0.000602	0.000602	CcSEcCtD
Gadodiamide—Urethral disorder—Doxorubicin—kidney cancer	0.000601	0.000601	CcSEcCtD
Gadodiamide—Dyspepsia—Capecitabine—kidney cancer	0.000595	0.000595	CcSEcCtD
Gadodiamide—Visual impairment—Doxorubicin—kidney cancer	0.000591	0.000591	CcSEcCtD
Gadodiamide—Asthenia—Paclitaxel—kidney cancer	0.000591	0.000591	CcSEcCtD
Gadodiamide—Nausea—Gemcitabine—kidney cancer	0.000584	0.000584	CcSEcCtD
Gadodiamide—Fatigue—Capecitabine—kidney cancer	0.000582	0.000582	CcSEcCtD
Gadodiamide—Pruritus—Paclitaxel—kidney cancer	0.000582	0.000582	CcSEcCtD
Gadodiamide—Pain—Capecitabine—kidney cancer	0.000578	0.000578	CcSEcCtD
Gadodiamide—Tinnitus—Doxorubicin—kidney cancer	0.000571	0.000571	CcSEcCtD
Gadodiamide—Flushing—Doxorubicin—kidney cancer	0.000569	0.000569	CcSEcCtD
Gadodiamide—Diarrhoea—Paclitaxel—kidney cancer	0.000563	0.000563	CcSEcCtD
Gadodiamide—Feeling abnormal—Capecitabine—kidney cancer	0.000557	0.000557	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Capecitabine—kidney cancer	0.000552	0.000552	CcSEcCtD
Gadodiamide—Chills—Doxorubicin—kidney cancer	0.00055	0.00055	CcSEcCtD
Gadodiamide—Arrhythmia—Doxorubicin—kidney cancer	0.000548	0.000548	CcSEcCtD
Gadodiamide—Dizziness—Paclitaxel—kidney cancer	0.000544	0.000544	CcSEcCtD
Gadodiamide—Urticaria—Capecitabine—kidney cancer	0.000537	0.000537	CcSEcCtD
Gadodiamide—Abdominal pain—Capecitabine—kidney cancer	0.000534	0.000534	CcSEcCtD
Gadodiamide—Body temperature increased—Capecitabine—kidney cancer	0.000534	0.000534	CcSEcCtD
Gadodiamide—Vomiting—Paclitaxel—kidney cancer	0.000523	0.000523	CcSEcCtD
Gadodiamide—Dysgeusia—Doxorubicin—kidney cancer	0.000522	0.000522	CcSEcCtD
Gadodiamide—Rash—Paclitaxel—kidney cancer	0.000519	0.000519	CcSEcCtD
Gadodiamide—Dermatitis—Paclitaxel—kidney cancer	0.000519	0.000519	CcSEcCtD
Gadodiamide—Headache—Paclitaxel—kidney cancer	0.000516	0.000516	CcSEcCtD
Gadodiamide—Hypersensitivity—Capecitabine—kidney cancer	0.000498	0.000498	CcSEcCtD
Gadodiamide—Ill-defined disorder—Doxorubicin—kidney cancer	0.000495	0.000495	CcSEcCtD
Gadodiamide—Nausea—Paclitaxel—kidney cancer	0.000489	0.000489	CcSEcCtD
Gadodiamide—Asthenia—Capecitabine—kidney cancer	0.000485	0.000485	CcSEcCtD
Gadodiamide—Malaise—Doxorubicin—kidney cancer	0.000481	0.000481	CcSEcCtD
Gadodiamide—Syncope—Doxorubicin—kidney cancer	0.000478	0.000478	CcSEcCtD
Gadodiamide—Pruritus—Capecitabine—kidney cancer	0.000478	0.000478	CcSEcCtD
Gadodiamide—Loss of consciousness—Doxorubicin—kidney cancer	0.000469	0.000469	CcSEcCtD
Gadodiamide—Convulsion—Doxorubicin—kidney cancer	0.000462	0.000462	CcSEcCtD
Gadodiamide—Diarrhoea—Capecitabine—kidney cancer	0.000462	0.000462	CcSEcCtD
Gadodiamide—Myalgia—Doxorubicin—kidney cancer	0.000454	0.000454	CcSEcCtD
Gadodiamide—Chest pain—Doxorubicin—kidney cancer	0.000454	0.000454	CcSEcCtD
Gadodiamide—Arthralgia—Doxorubicin—kidney cancer	0.000454	0.000454	CcSEcCtD
Gadodiamide—Anxiety—Doxorubicin—kidney cancer	0.000453	0.000453	CcSEcCtD
Gadodiamide—Discomfort—Doxorubicin—kidney cancer	0.000449	0.000449	CcSEcCtD
Gadodiamide—Dizziness—Capecitabine—kidney cancer	0.000447	0.000447	CcSEcCtD
Gadodiamide—Dry mouth—Doxorubicin—kidney cancer	0.000444	0.000444	CcSEcCtD
Gadodiamide—Oedema—Doxorubicin—kidney cancer	0.000435	0.000435	CcSEcCtD
Gadodiamide—Anaphylactic shock—Doxorubicin—kidney cancer	0.000435	0.000435	CcSEcCtD
Gadodiamide—Infection—Doxorubicin—kidney cancer	0.000433	0.000433	CcSEcCtD
Gadodiamide—Vomiting—Capecitabine—kidney cancer	0.00043	0.00043	CcSEcCtD
Gadodiamide—Shock—Doxorubicin—kidney cancer	0.000428	0.000428	CcSEcCtD
Gadodiamide—Nervous system disorder—Doxorubicin—kidney cancer	0.000427	0.000427	CcSEcCtD
Gadodiamide—Rash—Capecitabine—kidney cancer	0.000426	0.000426	CcSEcCtD
Gadodiamide—Dermatitis—Capecitabine—kidney cancer	0.000426	0.000426	CcSEcCtD
Gadodiamide—Tachycardia—Doxorubicin—kidney cancer	0.000425	0.000425	CcSEcCtD
Gadodiamide—Headache—Capecitabine—kidney cancer	0.000423	0.000423	CcSEcCtD
Gadodiamide—Hyperhidrosis—Doxorubicin—kidney cancer	0.000421	0.000421	CcSEcCtD
Gadodiamide—Hypotension—Doxorubicin—kidney cancer	0.000407	0.000407	CcSEcCtD
Gadodiamide—Nausea—Capecitabine—kidney cancer	0.000401	0.000401	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000397	0.000397	CcSEcCtD
Gadodiamide—Paraesthesia—Doxorubicin—kidney cancer	0.000391	0.000391	CcSEcCtD
Gadodiamide—Dyspnoea—Doxorubicin—kidney cancer	0.000388	0.000388	CcSEcCtD
Gadodiamide—Somnolence—Doxorubicin—kidney cancer	0.000387	0.000387	CcSEcCtD
Gadodiamide—Dyspepsia—Doxorubicin—kidney cancer	0.000383	0.000383	CcSEcCtD
Gadodiamide—Fatigue—Doxorubicin—kidney cancer	0.000375	0.000375	CcSEcCtD
Gadodiamide—Pain—Doxorubicin—kidney cancer	0.000372	0.000372	CcSEcCtD
Gadodiamide—Feeling abnormal—Doxorubicin—kidney cancer	0.000359	0.000359	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000356	0.000356	CcSEcCtD
Gadodiamide—Urticaria—Doxorubicin—kidney cancer	0.000346	0.000346	CcSEcCtD
Gadodiamide—Abdominal pain—Doxorubicin—kidney cancer	0.000344	0.000344	CcSEcCtD
Gadodiamide—Body temperature increased—Doxorubicin—kidney cancer	0.000344	0.000344	CcSEcCtD
Gadodiamide—Hypersensitivity—Doxorubicin—kidney cancer	0.000321	0.000321	CcSEcCtD
Gadodiamide—Asthenia—Doxorubicin—kidney cancer	0.000312	0.000312	CcSEcCtD
Gadodiamide—Pruritus—Doxorubicin—kidney cancer	0.000308	0.000308	CcSEcCtD
Gadodiamide—Diarrhoea—Doxorubicin—kidney cancer	0.000298	0.000298	CcSEcCtD
Gadodiamide—Dizziness—Doxorubicin—kidney cancer	0.000288	0.000288	CcSEcCtD
Gadodiamide—Vomiting—Doxorubicin—kidney cancer	0.000277	0.000277	CcSEcCtD
Gadodiamide—Rash—Doxorubicin—kidney cancer	0.000275	0.000275	CcSEcCtD
Gadodiamide—Dermatitis—Doxorubicin—kidney cancer	0.000274	0.000274	CcSEcCtD
Gadodiamide—Headache—Doxorubicin—kidney cancer	0.000273	0.000273	CcSEcCtD
Gadodiamide—Nausea—Doxorubicin—kidney cancer	0.000259	0.000259	CcSEcCtD
